Digital Health Startups

Curiato develops a smart surface monitoring system that uses the bed surface to continuously track patient pressure and humidity, generating clinical-grade data and insights. Its interoperable platform is designed for healthcare facilities to integrate with their data ecosystems and command centre applications.

1 investor

Curio provides mental health care services focused on closing health equity gaps for women, leveraging a team with expertise in healthcare, regulatory affairs, and clinical research.

1 investor

Curist is a direct-to-consumer brand offering affordable over-the-counter medications for symptoms including allergies, heartburn, arthritis, acne, and pain, with guidance from doctor advisors. It aims to increase access to affordable medication and improve at-home self-treatment.

1 investor

Curovate offers digital physical therapy and rehabilitation guidance for people recovering from or considering knee replacement and other joint or orthopedic conditions. Its content and app support patients through recovery with exercise and recovery tracking.

1 investor

Curtana Pharmaceuticals develops small molecule drugs targeting cancer stem cells in brain tumors, specifically gliomas and related CNS malignancies. The company focuses on OLIG2 inhibition to overcome treatment resistance and recurrence in pediatric and adult brain cancers.

1 investor

Curv is an AI-powered mobile app for cheer athletes that provides personalized training programs, a 24/7 AI coach, and progress benchmarking based on athletic performance data. It also offers college scouting exposure through invite-only showcases and leaderboards, plus optional 1-on-1 coaching from nutritionists, mental performance coaches, and strength trainers.

1 investor

CustomSurg develops digital solutions for orthopaedic trauma surgery, combining clinical expertise with data science and advanced technology. The company serves surgeons and clinical institutions globally.

1 investor

Cuvris builds specialty-focused AI agents that automate healthcare practice operations, including referral triage, patient intake, qualification, scheduling, and clinical documentation. It serves care teams and medical practices to reduce administrative workload, improve chart accuracy, and lower claim denials.

1 investor

CVAid develops an AI-powered stroke triage platform using standard smartphones and mobile applications to enable early diagnosis, in-hospital process management, and post-discharge follow-up. The company serves healthcare providers and stroke patients globally.

1 investor

CVS Health is a health care company that connects people to care through insurance plans, retail and specialty pharmacies, prescription delivery, walk-in appointments, and a pharmacy benefit manager. It serves individuals and families in the United States, offering services to manage chronic conditions, mental and physical well-being, and access to affordable medications.

1 investor

Cx Precision Medicine develops blood-based diagnostic tests for Alzheimer's and other neurodegenerative diseases, delivering precision medicine tools for early diagnosis and personalized treatment in primary care settings.

1 investor

Cyclerion is a biopharmaceutical company developing therapeutics for neuropsychiatric diseases, with a lead candidate (CYC-126) for treatment-resistant depression that pairs anesthetic agents with a personalized biofeedback-driven device. It targets patients, providers, and health systems seeking individualized mental health treatment.

1 investor

Cyclops Medtech develops a portfolio of vestibular diagnostic and therapy products—including videonystagmography (VNG/VOG), video head impulse testing (vHIT), dynamic visual acuity, stabilometry platforms, VR-based vestibular rehabilitation, and a smart balance board—to diagnose and treat dizziness and balance disorders. Its tools serve clinicians across neurotology, neurology, physiotherapy, audiology, and ophthalmology.

1 investor

Cynapsus is a specialty central nervous system pharmaceutical company developing a fast-acting sublingual thin film for on-demand management of OFF episodes in Parkinson's disease patients. Its lead candidate, APL-130277, is a sublingual formulation of apomorphine intended as an alternative to subcutaneous injection, and had entered Phase 3 clinical development.

1 investor

Cyrebro Neurosignals develops a neurotechnology platform using EEG and AI to analyze brain activity in real time, providing digital neuromarkers for healthcare applications and consumer product development. The platform serves healthcare professionals, clinical researchers, and consumer product companies in mental health, neurological treatment, and product optimization.

1 investor

CyrenCare provides digital patient intake software that captures clinical information through customizable forms and generates clinician-friendly reports for healthcare providers. The platform supports multilingual service delivery.

1 investor

Cytokinetics develops potential medicines for cardiovascular and neuromuscular diseases characterized by impaired muscle function. The company specializes in sarcomere-directed therapies targeting conditions involving muscle weakness, loss, and dysfunction.

1 investor

Cytura Therapeutics is a pharmaceutical company focused on drug discovery and development, with backing from academic research institutions and venture capital firms specializing in biotech and medtech investments.

1 investor

D2Type provides AI-enabled, lifestyle-first diabetes and cardiometabolic care delivered as between-visit clinical support, using proactive monitoring, early detection, and human clinical escalation to complement therapies like GLP-1s. It partners with health systems, employers, health plans, and clinicians to advance value-based care and reduce avoidable admissions and complications.

1 investor

Dadadoc Healthcare operates a telemedicine service for pediatric care in South Korea, letting patients consult with medical staff in real time and receive prescriptions without visiting a hospital. It also offers a digital health product using a smart thermometer that automatically syncs temperature data to a mobile app for tracking and sharing.

1 investor

Daisies is a women's health telemedicine app in Mexico offering a membership that provides access to female doctors across 20+ specialties, including gynecology, psychology, nutrition, general health, and training. It provides on-demand video consultations, digital prescriptions, a shared encrypted medical record, and clinical self-assessments, available 24/7 via mobile.</parameter> <parameter name="hq_country">MX

1 investor

DalCor Pharmaceuticals is a biopharmaceutical company developing dalcetrapib, a pharmacogenetic precision medicine for cardiovascular disease that targets patients with the ADCY9 AA genotype. The drug is being evaluated in Phase 3 clinical trials to reduce fatal and non-fatal myocardial infarction in post-acute coronary syndrome patients.

1 investor

The International Cystic Fibrosis Training Network (ICFTN) provides training, mentorship, and clinical development support to multidisciplinary cystic fibrosis care teams worldwide. It works with patients, families, and care centers to improve clinical processes and patient outcomes in CF care globally.

1 investor

Dalton Bioanalytics develops comprehensive biochemical analysis of humans in a single test, aimed at advancing preventative healthcare.

1 investor